Published in AIDS Educ Prev on December 01, 2005
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis (2011) 16.88
The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDS (2014) 1.94
Using HIV surveillance data to monitor missed opportunities for linkage and engagement in HIV medical care. Open AIDS J (2012) 1.08
Understanding people who have never received HIV medical care: a population-based approach. Public Health Rep (2010) 1.06
Accuracy of definitions for linkage to care in persons living with HIV. J Acquir Immune Defic Syndr (2013) 1.02
Hospitalization rates of people living with HIV in the United States, 2009. Public Health Rep (2014) 0.92
Who's in and who's out: use of primary medical care among people living with HIV. Am J Public Health (2007) 0.89
Tailored treatment for HIV+ persons with mental illness: the intervention cascade. J Acquir Immune Defic Syndr (2013) 0.83
Criminal justice involvement history is associated with better HIV care continuum metrics among a population-based sample of young black MSM. AIDS (2017) 0.78
Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave. BMJ Glob Health (2016) 0.76
Trajectory analyses of virologic outcomes reflecting community-based HIV treatment in Washington DC 1994-2012. BMC Public Health (2015) 0.75
Improving health outcomes for IPV-exposed women living with HIV. J Acquir Immune Defic Syndr (2013) 0.75
HIV prevention before HAART in sub-Saharan Africa. Lancet (2002) 5.55
Public health. Reassessing HIV prevention. Science (2008) 4.06
Costs and financial feasibility of malaria elimination. Lancet (2010) 3.15
The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. J Infect Dis (2004) 2.76
HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res (2007) 2.55
The Kenya AIDS Indicator Survey 2012: rationale, methods, description of participants, and response rates. J Acquir Immune Defic Syndr (2014) 2.54
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One (2012) 2.39
Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One (2012) 2.34
A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab. Clin Gastroenterol Hepatol (2013) 2.31
Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS One (2008) 2.31
The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol (2007) 2.19
Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep (2002) 2.14
Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One (2010) 2.12
The effect of health insurance on medical care utilization and implications for insurance expansion: a review of the literature. Med Care Res Rev (2005) 2.11
Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am (2006) 2.07
Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project. Health Serv Res (2004) 1.96
The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Appl Health Econ Health Policy (2009) 1.94
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS (2010) 1.83
HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency. BMC Public Health (2005) 1.83
Identifying barriers to HIV testing: personal and contextual factors associated with late HIV testing. AIDS Care (2011) 1.82
Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India. BMC Health Serv Res (2008) 1.69
Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India. BMC Health Serv Res (2005) 1.66
Sexual risk behaviour and viral suppression among HIV-infected adults receiving medical care in the United States. AIDS (2014) 1.61
Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia. PLoS One (2012) 1.57
Provision of syndromic treatment of sexually transmitted infections by community pharmacists: a potentially underutilized HIV prevention strategy. Sex Transm Dis (2003) 1.56
Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis (2002) 1.49
Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PLoS One (2011) 1.40
Changing cost of HIV interventions in the context of scaling-up in India. AIDS (2008) 1.39
Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009. MMWR Surveill Summ (2014) 1.36
Disparities in engagement in care and viral suppression among persons with HIV. J Acquir Immune Defic Syndr (2013) 1.34
Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr (2003) 1.31
Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr (2002) 1.30
Viagra use in a community-recruited sample of men who have sex with men, San Francisco. J Acquir Immune Defic Syndr (2003) 1.29
Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. J Acquir Immune Defic Syndr (2007) 1.20
Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med (2011) 1.19
Antiretroviral treatment scale-up among persons living with HIV in Kenya: results from a nationally representative survey. J Acquir Immune Defic Syndr (2014) 1.19
The cost of a rapid-test VCT clinic in South Africa. S Afr Med J (2005) 1.15
Determinants of survival among HIV-infected chronic dialysis patients. J Am Soc Nephrol (2003) 1.13
"Before we used to get sick all the time": perceptions of malaria and use of long-lasting insecticide-treated bed nets (LLINs) in a rural Kenyan community. Malar J (2010) 1.12
The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda. AIDS (2006) 1.10
The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med (2013) 1.10
Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance. AIDS (2013) 1.10
Using HIV surveillance data to monitor missed opportunities for linkage and engagement in HIV medical care. Open AIDS J (2012) 1.08
Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance. BMC Public Health (2013) 1.08
Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011. AIDS Patient Care STDS (2014) 1.05
HIV infection - United States, 2008 and 2010. MMWR Surveill Summ (2013) 1.02
Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007-2011. J Infect Dis (2013) 0.98
The influence of perceptions of HIV infection, care, and identity on care entry. AIDS Care (2011) 0.98
The impact of male circumcision on HIV transmission. J Urol (2010) 0.97
Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States. J Acquir Immune Defic Syndr (2014) 0.95
Adherence to antiretroviral therapy among HIV-infected adults in the United States. AIDS Educ Prev (2014) 0.94
HIV testing behaviors and knowledge of HIV reporting regulations among male-to-female transgenders. J Acquir Immune Defic Syndr (2004) 0.94
Frequent international travel by men who have sex with men recently diagnosed with HIV-1: potential for transmission of primary HIV-1 drug resistance. J Travel Med (2008) 0.94
Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies. Public Health Rep (2002) 0.93
Peering into the black box: billing and insurance activities in a medical group. Health Aff (Millwood) (2009) 0.93
Use of the non-pneumatic anti-shock garment (NASG) for life-threatening obstetric hemorrhage: a cost-effectiveness analysis in Egypt and Nigeria. PLoS One (2013) 0.92
Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus. Int J Gynaecol Obstet (2011) 0.91
Health state utility in patients with osteoarthritis of the hip and total hip arthroplasty. J Arthroplasty (2011) 0.91
Receipt of HIV/STD prevention counseling by HIV-infected adults receiving medical care in the United States. AIDS (2014) 0.90
Patient preferences and willingness to pay for arthroplasty surgery in patients with osteoarthritis of the hip. J Arthroplasty (2011) 0.90
HIV counseling, testing and referral experiences of persons diagnosed with HIV who have never entered HIV medical care. AIDS Educ Prev (2011) 0.89
Engagement in HIV care among Kenyan adults and adolescents: results from a national population-based survey. J Acquir Immune Defic Syndr (2014) 0.89
Elevated risk of death for African Americans with AIDS, San Francisco, 1996-2002. J Health Care Poor Underserved (2006) 0.88
The decline of incident cases of HIV-associated neurological disorders in San Francisco, 1991-2003. AIDS (2005) 0.87
The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry. AIDS (2011) 0.87
Cost-effectiveness of home-based chlorination and safe water storage in reducing diarrhea among HIV-affected households in rural Uganda. Am J Trop Med Hyg (2006) 0.85
Missed connections: HIV-infected people never in care. Public Health Rep (2013) 0.85
Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study. Cost Eff Resour Alloc (2011) 0.85
Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis. Curr HIV Res (2011) 0.84
Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa. J Acquir Immune Defic Syndr (2016) 0.83
A qualitative assessment of beliefs, attitudes, and behaviors related to diarrhea and water filtration in rural Kenya. Am J Public Health (2011) 0.83
Saving lives and saving money: hospital-based violence intervention is cost-effective. J Trauma Acute Care Surg (2015) 0.83
Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting. Curr HIV Res (2011) 0.82
Provision of bednets and water filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan multisite study. Trop Med Int Health (2013) 0.81
Preventing HIV in injection drug users: choosing the best mix of interventions for the population. J Urban Health (2003) 0.80
Viral load monitoring for antiretroviral therapy in resource-poor settings: an evolving role. AIDS (2013) 0.79
Disparities and Trends in Viral Suppression During a Transition to a "Test and Treat" Approach to the HIV Epidemic, San Francisco, 2008-2012. J Acquir Immune Defic Syndr (2015) 0.79
Sexual compulsiveness and change in unprotected anal intercourse: unexpected results from a randomized controlled HIV counseling intervention study. J Acquir Immune Defic Syndr (2008) 0.79
Adult male circumcision in Nyanza, Kenya at scale: the cost and efficiency of alternative service delivery modes. BMC Health Serv Res (2014) 0.79
Prevention counseling practices of HIV care providers with patients new to HIV medical care: medical monitoring project provider survey, 2009. J Int Assoc Provid AIDS Care (2014) 0.78
Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection. AIDS (2016) 0.77
How well do trends in HIV prevalence in young people reflect HIV incidence? Results from 10 years of HIV serosurveillance in San Francisco. AIDS (2006) 0.77
Estimating the return of persons living with HIV/AIDS to New Orleans: methods for conducting disease surveillance in the wake of a natural disaster. Am J Public Health (2008) 0.76
Integrated disease prevention campaigns: assessing country opportunity for implementation via an index approach. BMJ Open (2014) 0.76
Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation (2016) 0.75
Billing and insurance-related administrative costs in United States' health care: synthesis of micro-costing evidence. BMC Health Serv Res (2014) 0.75
Correction: Cost-Effectiveness Of Treatment Strategies for BRAF-Mutated Metastatic Melanoma. PLoS One (2015) 0.75
Estimating the Prevalence and Predictors of Incorrect Condom Use Among Sexually Active Adults in Kenya: Results From a Nationally Representative Survey. Sex Transm Dis (2016) 0.75
Unmet needs for HIV ancillary care services by health care coverage and Ryan White HIV/AIDS program assistance. AIDS (2022) 0.75
Increasing access to care for the uninsured: considering the options in California counties. J Health Care Poor Underserved (2006) 0.75
Barriers to Universal Prescribing of Antiretroviral Therapy by HIV Care Providers in the United States, 2013-2014. J Acquir Immune Defic Syndr (2017) 0.75
MSJAMA: Government share of health care expenditures. JAMA (2003) 0.75
Cost and efficiency of a hybrid mobile multi-disease testing approach with high HIV testing coverage in East Africa. J Acquir Immune Defic Syndr (2016) 0.75
Difference in Survival between Housed and Homeless individuals with HIV, San Francisco, 2002-2011. J Health Care Poor Underserved (2015) 0.75